Health Care & Life Sciences » Pharmaceuticals | USANA Health Sciences Inc.

USANA Health Sciences Inc. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
718
790
918
1,006
1,047
1,189
Cost of Goods Sold (COGS) incl. D&A
136
150
170
194
195
217
Gross Income
582
641
749
812
852
972
SG&A Expense
465
525
607
674
719
783
EBIT
117
116
142
139
133
188
Non Operating Income/Expense
1
1
-
1
-
1
Interest Expense
-
-
-
-
-
-
Pretax Income
117
116
143
139
135
192
Income Tax
38
39
48
39
72
65
Consolidated Net Income
79
77
95
100
63
126
Net Income
79
77
95
100
63
126
Net Income After Extraordinaries
79
77
95
100
63
126
Net Income Available to Common
79
77
95
100
63
126
EPS (Basic)
2.78
2.80
3.59
3.99
2.53
5.12
Basic Shares Outstanding
27
26
25
24
24
24
EPS (Diluted)
2.78
2.80
3.59
3.99
2.53
5.12
Diluted Shares Outstanding
28
27
26
25
25
25
EBITDA
126
125
152
152
148
205
Non-Operating Interest Income
-
1
1
1
2
4

About USANA Health Sciences

View Profile
Address
3838 West Parkway Boulevard
Salt Lake City Utah 84120
United States
Employees -
Website http://www.usana.com
Updated 07/08/2019
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. Its product line divided into four categories: Essentials, Optimizers, Foods, and Sense-beautiful science. The Essentials Nutritionals category includes vitamin and mineral supplements that provide a foundation of advanced total body nutrition for every age group.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.